Salvin S - Search Results

1

Controversies on rituximab therapy in sjögren syndrome-associated lymphoproliferation.

Quartuccio L, Fabris M, Salvin S, Maset M, De Marchi G, De Vita S. Quartuccio L, et al. Among authors: salvin s. Int J Rheumatol. 2009;2009:424935. doi: 10.1155/2009/424935. Epub 2010 Jan 28. Int J Rheumatol. 2009. PMID: 20148068 Free PMC article.

2

Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy.

De Vita S, Quartuccio L, Salvin S, Corazza L, Zabotti A, Fabris M. De Vita S, et al. Among authors: salvin s. Rheumatology (Oxford). 2012 Apr;51(4):627-33. doi: 10.1093/rheumatology/ker407. Epub 2011 Dec 30. Rheumatology (Oxford). 2012. PMID: 22210656

3

BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands.

Quartuccio L, Salvin S, Fabris M, Maset M, Pontarini E, Isola M, De Vita S. Quartuccio L, et al. Among authors: salvin s. Rheumatology (Oxford). 2013 Feb;52(2):276-81. doi: 10.1093/rheumatology/kes180. Epub 2012 Aug 9. Rheumatology (Oxford). 2013. PMID: 22879463

4

High prevalence of Chlamydophila psittaci subclinical infection in Italian patients with Sjögren's syndrome and parotid gland marginal zone B-cell lymphoma of MALT-type.

Fabris M, Dolcetti R, Pasini E, Quartuccio L, Pontarini E, Salvin S, Ponzoni M, Scott CA, De Vita S. Fabris M, et al. Among authors: salvin s. Clin Exp Rheumatol. 2014 Jan-Feb;32(1):61-5. Epub 2014 Jan 20. Clin Exp Rheumatol. 2014. PMID: 24447326

5

Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy.

De Vita S, Quartuccio L, Salvin S, Picco L, Scott CA, Rupolo M, Fabris M. De Vita S, et al. Among authors: salvin s. Clin Exp Rheumatol. 2014 Jul-Aug;32(4):490-4. Epub 2014 May 7. Clin Exp Rheumatol. 2014. PMID: 24802131

6

Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study.

Quartuccio L, Salvin S, Corazza L, Gandolfo S, Fabris M, De Vita S. Quartuccio L, et al. Among authors: salvin s. Clin Exp Rheumatol. 2016 Mar-Apr;34(2):311-4. Epub 2016 Feb 9. Clin Exp Rheumatol. 2016. PMID: 26886154 Clinical Trial.

7

Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis.

Quartuccio L, Fabris M, Salvin S, Atzeni F, Saracco M, Benucci M, Cimmino M, Morassi P, Masolini P, Pellerito R, Cutolo M, Puttini PS, De Vita S. Quartuccio L, et al. Among authors: salvin s. Rheumatology (Oxford). 2009 Dec;48(12):1557-9. doi: 10.1093/rheumatology/kep314. Epub 2009 Sep 29. Rheumatology (Oxford). 2009. PMID: 19789202

8

The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers.

Fabris M, Quartuccio L, Vital E, Pontarini E, Salvin S, Fabro C, Zabotti A, Benucci M, Manfredi M, Ravagnani V, Biasi D, Atzeni F, Sarzi-Puttini P, Morassi P, Fischetti F, Bazzicchi L, Saracco M, Pellerito R, Cimmino M, Carraro V, Semeraro A, Schiavon F, Caporali R, Bortolotti R, Govoni M, Fogolari F, Tonutti E, Bombardieri S, Emery P, De Vita S. Fabris M, et al. Among authors: salvin s. Arthritis Rheum. 2013 Jan;65(1):88-97. doi: 10.1002/art.37707. Arthritis Rheum. 2013. PMID: 23001900 Free article.

9

The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study.

Quartuccio L, Fabris M, Pontarini E, Salvin S, Zabotti A, Benucci M, Manfredi M, Biasi D, Ravagnani V, Atzeni F, Sarzi-Puttini P, Morassi P, Fischetti F, Tomietto P, Bazzichi L, Saracco M, Pellerito R, Cimmino M, Schiavon F, Carraro V, Semeraro A, Caporali R, Cavagna L, Bortolotti R, Paolazzi G, Govoni M, Bombardieri S, De Vita S. Quartuccio L, et al. Among authors: salvin s. Ann Rheum Dis. 2014 Apr;73(4):716-21. doi: 10.1136/annrheumdis-2012-202435. Epub 2013 Mar 16. Ann Rheum Dis. 2014. PMID: 23505228

10

Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.

Quartuccio L, Isola M, Baldini C, Priori R, Bartoloni Bocci E, Carubbi F, Maset M, Gregoraci G, Della Mea V, Salvin S, De Marchi G, Luciano N, Colafrancesco S, Alunno A, Giacomelli R, Gerli R, Valesini G, Bombardieri S, De Vita S. Quartuccio L, et al. Among authors: salvin s. J Autoimmun. 2014 Jun;51:75-80. doi: 10.1016/j.jaut.2013.10.002. Epub 2013 Nov 11. J Autoimmun. 2014. PMID: 24231556

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters